BioCardia Files 8-K: Other Events & Financials
Ticker: BCDA · Form: 8-K · Filed: Apr 11, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, corporate-update
TL;DR
BioCardia dropped an 8-K on 4/11. Check it for other events and financials.
AI Summary
BioCardia, Inc. filed an 8-K on April 11, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is incorporated in Delaware and headquartered in Sunnyvale, California.
Why It Matters
This filing provides an update on BioCardia's corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant events or financial updates without immediate market-moving news.
Key Numbers
- 001-38999 — Commission File Number (SEC filing identifier)
- 23-2753988 — IRS Employer Identification No. (Company tax identifier)
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- April 11, 2025 (date) — Date of earliest event reported
- Tiger X Medical, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Sunnyvale, California (location) — Principal executive offices
FAQ
What specific 'Other Events' are detailed in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
When was BioCardia, Inc. previously known as Tiger X Medical, Inc.?
The date of the name change from Tiger X Medical, Inc. to BioCardia, Inc. was June 16, 2011.
What is BioCardia's primary business classification according to the SIC code?
BioCardia's Standard Industrial Classification (SIC) code is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Where are BioCardia's principal executive offices located?
BioCardia's principal executive offices are located at 320 Soquel Way, Sunnyvale, California 94085.
What is the fiscal year end for BioCardia, Inc.?
BioCardia, Inc.'s fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 11, 2025 regarding BioCardia, Inc. (BCDA).